Public filings / AXSM on Yahoo Finance (opens in a new tab)
AXSM: insider buying, 13F holders, analyst moves
Axsome Therapeutics Inc - US
A summary of public filings about Axsome Therapeutics Inc - US. For the latest insider history, price chart, analyst changes and activist filings, open the live lookup.
SEC Form 13F · Q2 2026
5 of our 100 managers hold AXSM
Combined reported value $266.3M; 1 sold out since Q1 2026.
Holders among our 100 managers: 5 in Q3 2023, 5 in Q2 2026.
| Manager | Value | % of portfolio | Change vs Q1 2026 |
|---|---|---|---|
| Deep Track Capital | $171.3M | 2.52% | Trimmed |
| Samlyn Capital | $60.2M | 1.00% | New |
| Perceptive Advisors | $29.0M | 0.45% | Trimmed |
| Tudor Investment | $4.6M | 0.02% | New |
| Polen Capital | $1.1M | 0.01% | Added |
Important information
Facts from public SEC filings, shown for information only. Not a recommendation. Not individualized investment advice. Gulfstream Capital and its clients may hold positions in securities shown.